Go to virtual 3D site


Where: E6/E13
bit.bio is an award-winning human synthetic biology enterprise. bit.bio's mission is to code cells for novel cures. Our vision is biomedical innovation and a new generation of cures through precision engineered human cells.

bit.bio was founded out of CEO Mark Kotter’s laboratories at Cambridge University in 2016. Based on a unique approach to biology and the foundational capabilities to precisely reprogram human cells, bit.bio is poised to become a cornerstone in the upcoming regenerative medicine revolution. With just one cell type we are seeing a revolution in cancer care.

bit.bio is working to generalise this precision cellular reprogramming approach across the whole human cell type spectrum. The possibilities for research, drug discovery and novel cures for patients are endless. With a revolutionary range of definitive, coded cells - precision-engineered human iPSC-derived cells driven with our unique opti-ox™ technology that offer speed, reliability and consistency at scale for research and drug discovery.

"At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future." Mark Kotter | MD, PhD, Founder | CEO
Tel: 01223 787 297
Address: The Dorothy Hodgkin Building
Babraham Research Campus
Website: https://bit.bio/
Email: info@bit.bio

Book a Meeting

If you would like to talk to a representative of bit.bio at this event, you can book a meeting time here. Your request will be immediately forwarded to the team who will confirm a time with you.


Excel Arena
One Western Gateway Royal Victoria Dock London Hotels nearby

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Web Site Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2022